Chloroquine remains effective for treating Plasmodium vivax malaria in Pursat Province, western Cambodia

Antimicrobial Agents and Chemotherapy

Volumn 58, Issue 10, 2014, Pages 6270-6272

  Amaratunga, Chanaki ^a   Sreng, Sokunthea ^b   Mao, Sivanna ^c   Tullo, Gregory S ^a   Anderson, Jennifer M ^a   Chuor, Char Meng ^b   Suon, Seila ^b   Fairhurst, Rick M ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b National Center for Parasitology Entomology and Malaria Control   (Cambodia)

^c Sampov Meas Referral Hospital   (Cambodia)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMISININ; CHLOROQUINE; PARACETAMOL; PRIMAQUINE; ANTIINFECTIVE AGENT; ARTEMISININ DERIVATIVE;

ADOLESCENT; ADULT; AGED; ARTICLE; AXILLA TEMPERATURE; BLOOD SMEAR; CAMBODIA; CHILD; CHILL; FEMALE; FEVER; FOLLOW UP; GAMETOCYTE; HEADACHE; HEMATOCRIT; HUMAN; MAJOR CLINICAL STUDY; MALAISE; MALARIA FALCIPARUM; MALE; PARASITEMIA; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX MALARIA; SHIVERING; SWEAT; TREATMENT RESPONSE; VOMITING; DRUG EFFECTS; DRUG RESISTANCE; MALARIA; PLASMODIUM VIVAX;

ANTI-INFECTIVE AGENTS; ARTEMISININS; CAMBODIA; CHLOROQUINE; DRUG RESISTANCE; MALARIA; PLASMODIUM VIVAX;

EID: 84907436346     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.03026-14     Document Type: Article

References (17)

1. World Health Organization. 2013. World malaria report. World Health Organization, Geneva, Switzerland, http://www.who.int/malaria /pubhcations/world-maiaria-report-2013/report/en/.
2. Amaratunga C, Sreng S, Suon S, Phelps ES, Stepniewska K, Lim P, Zhou C, Mao S, Anderson JM, Lindegardh N, Jiang H, Song J, Su XZ, White NJ, Dondorp AM, Anderson TJ, Fay MP, Mu J, Duong S, Fairhurst RM. 2012. Artemisinin-resistant Plasmodium falciparum in Pursat province, western Cambodia: a parasite clearance rate study. Lancet Infect. Dis. 12:851-858. http://dx.doi.org/10.1016/S1473-3099(12) 70181-0.
3. Ariey F, Witkowski B, Amaratunga C, Beghain J, Langlois AC, Khim N, Kim S, Duru V, Bouchier C, Ma L, Lim P, Leang R, Duong S, Sreng S, Suon S, Chuor CM, Bout DM, Ménard S, Rogers WO, Genton B, Fandeur T, Miotto O, Ringwald P, Le Bras J, Berry A, Barale JC, Fairhurst RM, Benoit-Vical F, Mercereau-Puijalon O, Ménard D. 2014. A molecular marker of artemisinin-resistant Plasmodium falciparum malaria. Nature 505:50-55. http://dx.doi.org/10.1038/naturel2876.
4. Ashley EA, Dhorda M, Fairhurst RM, Amaratunga C, Lim P, Suon S, Sreng S, Anderson JM, Mao S, Sam B, Sopha C, Char MC, Nguon C, Sovannaroth S, Pukrittayakamee S, Jittamala P, Chotivanich K, Chutasmit K, Suchatsoonthorn C, Runcharoen R, Hien TT, Nguyen TTN, Ngo VT, Nguyen HP, Htut Y, Han KT, Aye KH, Mokuolu OA, Olaosebikan RR, Folaranmi 00, Mayxay M, Khanthavong M, Hongvanthong B, Newton PN, Onyamboko MA, Fanello CI, Tshefu AK, Mishra N, Valecha N, Phyo AP, Nosten F, Yi P, Tripura R, Borrmann S, Bashraheil M, Peshu J, Faiz MA, Chose A, Hossain MA, Samad R, et al. 2014. Spread of artemisinin resistance in Plasmodium falciparum malaria. N. Engl. J. Med. 371:411-423. http://dx.doi.org/10.1056/NEJMoa1314981.
5. Royal Government of Cambodia. 2011. National strategic plan for elimination of malaria in the Kingdom of Cambodia, 2011-2025. National Malaria Center, Phnom Penh, Cambodia, http://www.cnm.gov.kh/userfiles /file/N%20Strategy%20Plan/National%20Strtegyin%20English.pdf.
6. Khim N, Benedet C, Kim S, Kheng S, Siv S, Leang R, Lek S, Muth S, Chea N, Chuor CM, Duong S, Kerleguer A, Tor P, Chim P, Canier L, Witkowski B, Taylor WR, Ménard D. 2013. G6PD deficiency in Plasmo- dium falciparum and Plasmodium vivax malaria-infected Cambodian patients. Malar. J. 12:171. http://dx.doi.org/10.1186/1475-2875-12-171.
7. Mendis K, Sina BJ, Marchesini P, Carter R. 2001. The neglected burden of Plasmodium vivax malaria. Am. J. Trop. Med. Hyg. 64:97-106.
8. Gogtay N, Kannan S, Thatte UM, Olliaro PL, Sinclair D. 2013. Artemisinin-based combination therapy for treating uncomplicated Plasmodium vivax malaria. Cochrane Database Syst. Rev. 10:CD008492. http://dx. doi.org/10.1002/14651858.CD008492.pub3.
9. World Health Organization. 2010. Guidelines for the treatment of malaria-2nd edition. World Health Organization, Geneva, Switzerland, http: //apps.who.int/medicinedocs/documents/sl9105en/s19105en.pdf.
10. Rieckmann KH, Davis DR, Hutton DC. 1989. Plasmodium vivax resistance to chloroquine? Lancet ii: 1183-1184.
11. Fryauff DJ, Tuti S, Mardi A, Masbar S, Patipelohi R, Leksana B, Kain KC, Bangs MJ, Richie TL, Baird JK. 1998. Chloroquine-resistant Plasmodium vivax in transmigration settlements of West Kalimantan, Indonesia. Am. J. Trop. Med. Hyg. 59:513-518.
12. Baird JK, Caneta-Miguel E, Masbar S, Bustos DG, Abrenica JA, Layawen AV, Calulut JM, Leksana B, Wignall FS. 1996. Survey of resistance to chloroquine of falciparum and vivax malaria in Palawan, the Philippines. Trans. R Soc. Trop. Med. Hyg. 90:413-414. http://dx.doi.org/10 .1016/50035-9203(96)90528-3.
13. de Santana Filho FS, Arcanjo AR, Chehuan YM, Costa MR, MartinezEspinosa FE, Vieira JL, Barbosa Md, Alecrim WD, Alecrim Md. 2007. Chloroquine-resistant Plasmodium vivax, Brazilian Amazon. Emerg. Infect. Dis. 13:1125-1126. http://dx.doi.org/10.3201/eidl307.061386.
14. Phyo AP, Lwin KM, Price RN, Ashley EA, Russell B, Sriprawat K, Lindegardh N, Singhasivanon P, White NJ, Nosten F. 2011. Dihydroartemisinin-piperaquine versus chloroquine in the treatment of Plasmodium vivax malaria in Thailand: a randomized controlled trial. Clin. Infect. Dis. 53:977-984. http://dx.doi.org/10.1093/cid/cir631.
15. Poravuth Y, Socheat D, Rueangweerayut R, Uthaisin C, Pyae Phyo A, Valecha N, Rao BH, Tjitra E, Pumama A, Borghini-Fuhrer I, Duparc S, Shin CS, Fleckenstein L. 2011. Pyronaridine-artesunate versus chloroquine in patients with acute Plasmodium vivax malaria: a randomized, double-blind, non-inferiority trial. PLoS One 6:el4501. http://dx.doi.org /10.1371/journal.pone.0014501.
16. Leang R, Barrette A, Bouth DM, Menard D, Abdur R, Duong S, Ringwald P. 2013. Efficacy of dihydroartemisinin-piperaquine for treatment of uncomplicated Plasmodium falciparum and Plasmodium vivax in Cambodia, 2008 to 2010. Antimicrob. Agents Chemother. 57:818-826. http://dx.doi.org/10.1128/AAC.00686-12.
17. World Health Organization. 2009. Methods for surveillance of antimalarial drug efficacy. World Health Organization, Geneva, Switzerland. http://whqlibdoc.who.int/publications/2009/9789241597531-eng.pdf